Literature DB >> 24952026

Human umbilical cord-derived mesenchymal stem cells differentiate into epidermal-like cells using a novel co-culture technique.

Dongjie Li1, Jiake Chai, Chuanan Shen, Yanfu Han, Tianjun Sun.   

Abstract

Human umbilical cord-derived mesenchymal stem cells (hUCMSCs) isolated from human umbilical Wharton's Jelly are a population of primitive and pluripotent cells. In specific conditions, hUCMSCs can differentiate into various cells, including adipocytes, osteoblasts, chondrocytes, neurocytes, and endothelial cells. However, few studies have assessed their differentiation into epidermal cells in vitro. To assess the potential of hUCMSCs to differentiate into epidermal cells, a microporous membrane-based indirect co-culture system was developed in this study. Epidermal stem cells (ESCs) were seeded on the bottom of the microporous membrane, and hUCMSCs were seeded on the top of the microporous membrane. Cell morphology was assessed by phase contrast microscopy, and the expression of early markers of epidermal cell lineage, P63, cytokeratin19 (CK19), and β1-integrin, was determined by immunofluorescence, Western blot, and quantitative real-time PCR (Q-PCR) analyses. hUCMSC morphology changed from spindle-like to oblate or irregular with indirect co-culture with ESCs; they also expressed greater levels P63, CK19, and β1-integrin mRNA and protein compared to the controls (p < 0.01). As compared to normal co-cultures, indirect co-culture expressed significantly greater CK19 protein (p < 0.01). Thus, hUCMSCs may have the capability to differentiate into the epidermal lineage in vitro, which may be accomplished through this indirect co-culture model.

Entities:  

Year:  2014        PMID: 24952026      PMCID: PMC4082775          DOI: 10.1007/s10616-013-9569-z

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  38 in total

1.  Morphogenesis and renewal of hair follicles from adult multipotent stem cells.

Authors:  H Oshima; A Rochat; C Kedzia; K Kobayashi; Y Barrandon
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

2.  Osteogenetic activity of transplanted transitional epithelium.

Authors:  A J FRIEDENSTEIN
Journal:  Acta Anat (Basel)       Date:  1961

3.  Transformation of human umbilical mesenchymal cells into neurons in vitro.

Authors:  Yu-Show Fu; Yu-Tsung Shih; Yun-Chih Cheng; Ming-Yuan Min
Journal:  J Biomed Sci       Date:  2004 Sep-Oct       Impact factor: 8.410

4.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

5.  Differentiation of bone marrow-derived mesenchymal stem cells into multi-layered epidermis-like cells in 3D organotypic coculture.

Authors:  Kun Ma; Filip Laco; Seeram Ramakrishna; Susan Liao; Casey K Chan
Journal:  Biomaterials       Date:  2009-03-13       Impact factor: 12.479

6.  Umbilical cord blood stem cells: induction of differentiation into mesenchymal lineages by cell-cell contacts with various mesenchymal cells.

Authors:  Jung Park; Viviane Setter; Viktor Wixler; Holm Schneider
Journal:  Tissue Eng Part A       Date:  2009-02       Impact factor: 3.845

7.  Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors.

Authors:  Rahul Sarugaser; David Lickorish; Dolores Baksh; M Morris Hosseini; John E Davies
Journal:  Stem Cells       Date:  2005-02       Impact factor: 6.277

8.  Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.

Authors:  Mark L Weiss; Satish Medicetty; Amber R Bledsoe; Raja Shekar Rachakatla; Michael Choi; Shosh Merchav; Yongquan Luo; Mahendra S Rao; Gopalrao Velagaleti; Deryl Troyer
Journal:  Stem Cells       Date:  2005-10-13       Impact factor: 6.277

9.  Multipotent stem cells from umbilical cord: cord is richer than blood!

Authors:  Mariane Secco; Eder Zucconi; Natassia M Vieira; Luciana L Q Fogaça; Antonia Cerqueira; Maria Denise F Carvalho; Tatiana Jazedje; Oswaldo K Okamoto; Alysson R Muotri; Mayana Zatz
Journal:  Stem Cells       Date:  2007-10-11       Impact factor: 6.277

10.  Mesenchymal precursor cells in the blood of normal individuals.

Authors:  N J Zvaifler; L Marinova-Mutafchieva; G Adams; C J Edwards; J Moss; J A Burger; R N Maini
Journal:  Arthritis Res       Date:  2000-08-31
View more
  5 in total

Review 1.  Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy.

Authors:  Justin D Glenn; Katharine A Whartenby
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

2.  Mesenchymal stem/stromal cells-a key mediator for regeneration after perinatal morbidity?

Authors:  Martin Mueller; Tim G A Wolfs; Andreina Schoeberlein; Antonio W D Gavilanes; Daniel Surbek; Boris W Kramer
Journal:  Mol Cell Pediatr       Date:  2016-02-11

Review 3.  Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.

Authors:  Juan Xiao; Rongbing Yang; Sangita Biswas; Xin Qin; Min Zhang; Wenbin Deng
Journal:  Int J Mol Sci       Date:  2015-04-24       Impact factor: 5.923

Review 4.  Using mesenchymal stem cells as a therapy for bone regeneration and repairing.

Authors:  Jin Shao; Weiwei Zhang; Tieyi Yang
Journal:  Biol Res       Date:  2015-11-03       Impact factor: 5.612

5.  Mesenchymal stem cells internalize Mycobacterium tuberculosis through scavenger receptors and restrict bacterial growth through autophagy.

Authors:  Arshad Khan; Lovepreet Mann; Ramesha Papanna; Mi-Ae Lyu; Christopher R Singh; Scott Olson; N Tony Eissa; Jeffrey Cirillo; Gobardhan Das; Robert L Hunter; Chinnaswamy Jagannath
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.